|
Volumn 111, Issue 9, 2004, Pages 1025-
|
Response to 'The drugs we deserve'
a b c d e |
Author keywords
[No Author keywords available]
|
Indexed keywords
ATOSIBAN;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
NIFEDIPINE;
OXYTOCIN ANTAGONIST;
RITODRINE;
UTERUS SPASMOLYTIC AGENT;
BRAIN HEMORRHAGE;
CAUSE OF DEATH;
CLINICAL TRIAL;
CONGENITAL MALFORMATION;
DRUG COST;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDICATION;
DRUG MECHANISM;
HUMAN;
LABOR COMPLICATION;
LETTER;
NECROTIZING ENTEROCOLITIS;
NEONATAL RESPIRATORY DISTRESS SYNDROME;
NEWBORN DEATH;
NEWBORN DISEASE;
PREMATURE LABOR;
PRIORITY JOURNAL;
CALCIUM CHANNEL BLOCKERS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
NIFEDIPINE;
OBSTETRIC LABOR, PREMATURE;
PREGNANCY;
RANDOMIZED CONTROLLED TRIALS;
TOCOLYTIC AGENTS;
|
EID: 4544356894
PISSN: 14700328
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1471-0528.2004.00261.x Document Type: Letter |
Times cited : (3)
|
References (5)
|